Dapazia 10

Dapagliflozin 10 mg

Type 2 diabetes mellitus (as an adjunct to diet and exercise) to improve glycaemic control; may also be used in certain patients with heart failure or chronic kidney disease as prescribed by a doctor

Dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys. It increases urinary glucose excretion, thereby lowering blood sugar, and can also produce mild diuresis and weight reduction.

Oral tablet. Usually taken once daily, with or without food, preferably at the same time each day. Swallow whole with water. Dose and duration as advised by the physician; maintain hydration.

Genital fungal infection, urinary tract infection, increased urination, thirst, dizziness, low blood sugar (when used with insulin/sulfonylurea), nausea

Not for type 1 diabetes or for treatment of diabetic ketoacidosis. Risk of genital mycotic infections, UTIs and rare Fournier’s gangrene—seek care for genital pain/swelling/fever. Can cause dehydration, low blood pressure and dizziness (higher risk in elderly, diuretic users). May cause ketoacidosis even with near-normal sugars—seek care for nausea, vomiting, abdominal pain, rapid breathing. Monitor kidney function; not recommended in severe renal impairment/end-stage kidney disease; stop temporarily during major surgery/acute illness as advised. Use caution with history of recurrent UTIs.

Insulin or sulfonylureas (increased hypoglycaemia risk), diuretics like furosemide/torasemide (dehydration/hypotension risk), antihypertensives (additive BP lowering), lithium (levels may decrease), other SGLT2 inhibitors (duplicate therapy)

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Forxiga 10 Tablet, Dapawin 10 Tablet, Dapacose 10 Tablet, Dapaglyn 10 Tablet, Oxra 10 Tablet